IL-28A/B (IFN-lambda 2/3) Products

1789-ML) reduces the Encephalomyocarditis Virus (EMCV)-induced cytopathy in the HepG2 human hepatocellular carcinoma cell line in a dose-dependent manner (orange line). Inhibition of EMCV activity elicited by Recombinant Mouse IL-28B/IFN-lambda 3 (400 ng/mL) is neutralized (green line) by increasing concentrations of Rat Anti-Mouse IL-28B/IFN-lambda 3 Monoclonal Antibody (Catalog # MAB17892). The ND₅₀ is typically 3-9 µg/mL." class="big_lightbox" target="_blank">

1789-ML) was serially diluted and captured by Rat Anti-Mouse IL‑28A/B (IFN‑ lambda 2/3) Monoclonal Antibody (Catalog # MAB17892) coated on a Clear Polystyrene Microplate (Catalog # DY990). Rat Anti-Mouse IL‑28A/B (IFN‑ lambda 2/3) Biotinylated Monoclonal Antibody (Catalog # [[catalogNumber:) was incubated with the protein captured on the plate. Detection of the standard curve was achieved by incubating Streptavidin-HRP (Catalog # [[catalogNumber:DY998)" class="big_lightbox" target="_blank">

1789-ML) was serially diluted and captured by Rat Anti-Mouse IL‑28A/B (IFN‑ lambda 2/3) Monoclonal Antibody (Catalog # MAB17892) coated on a Clear Polystyrene Microplate (Catalog # DY990). Rat Anti-Mouse IL‑28A/B (IFN‑ lambda 2/3) Biotinylated Monoclonal Antibody (Catalog # ) was incubated with the protein captured on the plate. Detection of the standard curve was achieved by incubating Streptavidin-HRP (Catalog # DY998)" class="big_lightbox" target="_blank">